| Akums Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544222 |
NSE Symbol : AKUMS |
P/E(TTM) : 139.11 |
|
ISIN Demat : INE09XN01023 |
Div & Yield% : - |
EPS(TTM) : 4.12 |
|
Book Value(₹) : 142.04 |
Market Cap(₹Cr) : 9,021.04 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|
| Gross Sales | 328.35 | 317.28 | 298.35 | 447.00 | 315.61 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 328.35 | 317.28 | 298.35 | 447.00 | 315.61 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 32.12 | 26.18 | 26.66 | 22.17 | 20.40 |
| Total Income | 360.47 | 343.45 | 325.02 | 469.17 | 336.01 |
| Total Expenditure | 285.28 | 273.59 | 360.18 | 375.79 | 502.77 |
| PBIDT | 75.19 | 69.86 | -35.16 | 93.38 | -166.75 |
| Interest | 4.18 | 6.21 | 4.80 | 4.51 | 4.17 |
| PBDT | 71.01 | 63.65 | -39.95 | 88.87 | -170.92 |
| Depreciation | 9.39 | 9.38 | 9.09 | 7.90 | 7.40 |
| Tax | 13.71 | 12.52 | 4.70 | 15.25 | 12.17 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.46 | -0.13 | 4.13 | 12.97 | -0.82 |
| Reported Profit After Tax | 50.37 | 41.88 | -57.87 | 52.75 | -189.67 |
| Extra-ordinary Items | 0.00 | 0.00 | -1.06 | -11.79 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 50.37 | 41.88 | -56.81 | 64.54 | -189.67 |
| EPS (Unit Curr.) | 3.38 | 2.93 | -4.04 | 3.69 | -13.26 |
| EPS (Adj) (Unit Curr.) | 3.38 | 2.93 | -4.04 | 3.69 | -13.26 |
| Calculated EPS (Unit Curr.) | 3.29 | 2.93 | -4.04 | 3.69 | -13.26 |
| Calculated EPS (Adj) (Unit Curr.) | 3.29 | 2.93 | -4.04 | 3.69 | -13.26 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.16 | 11.71 | -16.18 | 14.75 | -53.03 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.16 | 11.71 | -16.18 | 14.75 | -53.03 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 30.62 | 28.61 | 28.61 | 28.61 | 28.61 |
| Reserve & Surplus | 2,204.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.90 | 22.02 | -11.78 | 20.89 | -52.83 |
| PBDTM(%) | 21.63 | 20.06 | -13.39 | 19.88 | -54.16 |
| PATM(%) | 15.34 | 13.20 | -19.40 | 11.80 | -60.10 |